FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2989367089> ?p ?o ?g. }

• W2989367089 abstract "Abstract Background In healthy subjects fibrinogen γ/γ‘ circulates at 8–15% of the total plasma fibrinogen concentration. Elevated levels of this variant have been associated with arterial thrombosis, and its diminution with venous thrombosis. The aims of the present work were to analyze the structure of the fibrin network formed on the top of human dermal microvascular endothelial cells (HMEC-1) at different fibrinogen γ/γ‘ concentrations, as well as its influence on the secretion of fibrinolytic components. The kinetics of fibrin polymerization on top of HMEC-1 cells with 3, 10, and 30% fibrinogen γ/γ‘ was followed at 350 nm. The secretion of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI 1) by HMEC-1 were measured in the supernatant and cell lysates, after incubation with 1 nM thrombin, fibrin with 3, and 30% fibrinogen γ/γ‘, using commercial kits. The influence of fibrinogen γ/γ‘ on fibrin structure on the surface of the HMEC-1 was followed with laser scanning confocal microscopy (LSCM). Results The kinetics of fibrin formation on HMEC-1 with 3 and 10% fibrinogen γ/γ‘ were similar. However, with 30% fibrinogen γ/γ‘ both the slope and final turbity were approximately 50% less. The LSCM images showed the dramatic effects of increasing fibrinogen γ/γ‘ from 3 to 30%. The uPA and PAI 1 concentrations in culture supernatants HMEC-1 cells treated with thrombin or 30% γ/γ‘ fibrin were two-fold increased as compared to basal culture supernatants and 3% γ/γ‘ fibrin-treated HMEC-1. In all stimulatory conditions the intracellular concentration of uPA was higher than in supernatants. In contrast, the intracellular PAI 1 concentration was decreased as compared to that measured in the supernatant, including the basal condition. Conclusion A concentration of 30% fibrin γ/γ‘ alter drastically fibrin structure on the cell surface and affects the secretion of uPA and PAI 1 through its capacity to bind thrombin." @default.
• W2989367089 created "2019-11-22" @default.
• W2989367089 creator A5012128718 @default.
• W2989367089 creator A5032521884 @default.
• W2989367089 creator A5056779604 @default.
• W2989367089 creator A5068713469 @default.
• W2989367089 date "2019-11-01" @default.
• W2989367089 modified "2023-10-16" @default.
• W2989367089 title "Fibrin γ/γ' influences the secretion of fibrinolytic components and clot structure" @default.
• W2989367089 cites W126825949 @default.
• W2989367089 cites W1520222037 @default.
• W2989367089 cites W1587148305 @default.
• W2989367089 cites W1603365810 @default.
• W2989367089 cites W1711208506 @default.
• W2989367089 cites W1969964498 @default.
• W2989367089 cites W1980034965 @default.
• W2989367089 cites W1992952287 @default.
• W2989367089 cites W1993780126 @default.
• W2989367089 cites W1997729699 @default.
• W2989367089 cites W1998529033 @default.
• W2989367089 cites W1999324640 @default.
• W2989367089 cites W1999427778 @default.
• W2989367089 cites W2003843472 @default.
• W2989367089 cites W2010020730 @default.
• W2989367089 cites W2012839797 @default.
• W2989367089 cites W202019503 @default.
• W2989367089 cites W2020709050 @default.
• W2989367089 cites W2029604831 @default.
• W2989367089 cites W2039053151 @default.
• W2989367089 cites W2055369991 @default.
• W2989367089 cites W2056593430 @default.
• W2989367089 cites W2063348724 @default.
• W2989367089 cites W2077375327 @default.
• W2989367089 cites W2083010539 @default.
• W2989367089 cites W2085883586 @default.
• W2989367089 cites W2090549428 @default.
• W2989367089 cites W2092608701 @default.
• W2989367089 cites W2098327367 @default.
• W2989367089 cites W2122400280 @default.
• W2989367089 cites W2129427632 @default.
• W2989367089 cites W2146619312 @default.
• W2989367089 cites W2152143425 @default.
• W2989367089 cites W2161839431 @default.
• W2989367089 cites W2336326317 @default.
• W2989367089 cites W2337789228 @default.
• W2989367089 cites W2337841764 @default.
• W2989367089 cites W2339125582 @default.
• W2989367089 cites W2398448151 @default.
• W2989367089 cites W2584545556 @default.
• W2989367089 cites W2901168558 @default.
• W2989367089 doi "https://doi.org/10.1186/s12860-019-0233-0" @default.
• W2989367089 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6824120" @default.
• W2989367089 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31675913" @default.
• W2989367089 hasPublicationYear "2019" @default.
• W2989367089 type Work @default.
• W2989367089 sameAs 2989367089 @default.
• W2989367089 citedByCount "5" @default.
• W2989367089 countsByYear W29893670892020 @default.
• W2989367089 countsByYear W29893670892021 @default.
• W2989367089 countsByYear W29893670892022 @default.
• W2989367089 countsByYear W29893670892023 @default.
• W2989367089 crossrefType "journal-article" @default.
• W2989367089 hasAuthorship W2989367089A5012128718 @default.
• W2989367089 hasAuthorship W2989367089A5032521884 @default.
• W2989367089 hasAuthorship W2989367089A5056779604 @default.
• W2989367089 hasAuthorship W2989367089A5068713469 @default.
• W2989367089 hasBestOaLocation W29893670891 @default.
• W2989367089 hasConcept C126322002 @default.
• W2989367089 hasConcept C134018914 @default.
• W2989367089 hasConcept C153911025 @default.
• W2989367089 hasConcept C185592680 @default.
• W2989367089 hasConcept C203014093 @default.
• W2989367089 hasConcept C2776825266 @default.
• W2989367089 hasConcept C2777292125 @default.
• W2989367089 hasConcept C2779036427 @default.
• W2989367089 hasConcept C2779679481 @default.
• W2989367089 hasConcept C49039625 @default.
• W2989367089 hasConcept C54173615 @default.
• W2989367089 hasConcept C55493867 @default.
• W2989367089 hasConcept C71924100 @default.
• W2989367089 hasConcept C86803240 @default.
• W2989367089 hasConcept C89560881 @default.
• W2989367089 hasConceptScore W2989367089C126322002 @default.
• W2989367089 hasConceptScore W2989367089C134018914 @default.
• W2989367089 hasConceptScore W2989367089C153911025 @default.
• W2989367089 hasConceptScore W2989367089C185592680 @default.
• W2989367089 hasConceptScore W2989367089C203014093 @default.
• W2989367089 hasConceptScore W2989367089C2776825266 @default.
• W2989367089 hasConceptScore W2989367089C2777292125 @default.
• W2989367089 hasConceptScore W2989367089C2779036427 @default.
• W2989367089 hasConceptScore W2989367089C2779679481 @default.
• W2989367089 hasConceptScore W2989367089C49039625 @default.
• W2989367089 hasConceptScore W2989367089C54173615 @default.
• W2989367089 hasConceptScore W2989367089C55493867 @default.
• W2989367089 hasConceptScore W2989367089C71924100 @default.
• W2989367089 hasConceptScore W2989367089C86803240 @default.
• W2989367089 hasConceptScore W2989367089C89560881 @default.
• W2989367089 hasFunder F4320320883 @default.
• W2989367089 hasFunder F4320320893 @default.
• W2989367089 hasIssue "1" @default.

• next